Evelo Biosciences Inc (EVLO PINK) stock market data APIs
$0.0005
0(0%)
as of April 28, 2025
Evelo Biosciences Inc Financial Data Overview
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Prev. Close
0.0005
Open
0.0005
High
0.0005
Low
0.0005
52 wk Range
0.0001-0.063
Market Cap
9 491
Shares Outstanding
18 983 K
EPS
-0.7112
Beta
1.072
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evelo Biosciences Inc data using free add-ons & libraries
Get Evelo Biosciences Inc Fundamental Data
Evelo Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -69 674 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-11-09
- EPS/Forecast: -0.97
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evelo Biosciences Inc News
New
Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript
Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript November 1, 2023 Operator: Greetings, and welcome to Horizon Technology Finance Corporation Third Quarter 2023 Ea...
Q3 2023 Horizon Technology Finance Corp Earnings Call
Participants Daniel Raffaele Trolio; Executive VP, CFO & Treasurer; Horizon Technology Finance Corporation Gerald A. Michaud; President & Director; Horizon Technology Finance Corporation Megan N. B...
Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study
Shares of Evelo Biosciences EVLO plummeted 58.8% on Tuesday after its management announced disappointing top-line results from a mid-stage study evaluating EDP2939 in moderate psoriasis. The mid-stag...
Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More
It was a busy week for the biotech sector before the third-quarter earnings kicked in. While nothing important came from bigwigs, pipeline and regulatory updates from quite a few other biotechs were i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
